These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

232 related articles for article (PubMed ID: 37929738)

  • 1. Research Mechanism and Progress of the Natural Compound Curcumin in Treating Alzheimer´s Disease.
    Li L; Wang F; Jia X; Yao L; Liu Y
    Mini Rev Med Chem; 2024; 24(17):1590-1601. PubMed ID: 37929738
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The Mechanisms of Action of Curcumin in Alzheimer's Disease.
    Tang M; Taghibiglou C
    J Alzheimers Dis; 2017; 58(4):1003-1016. PubMed ID: 28527218
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Exploring Curcumin-Loaded Lipid-Based Nanomedicine as Efficient Targeted Therapy for Alzheimer's Diseases.
    Far BF; Safaei M; Pourmolaei A; Adibamini S; Shirdel S; Shirdel S; Emadi R; Kaushik AK
    ACS Appl Bio Mater; 2024 Jun; 7(6):3535-3555. PubMed ID: 38768054
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A Curcumin Analog Reduces Levels of the Alzheimer's Disease-Associated Amyloid-β Protein by Modulating AβPP Processing and Autophagy.
    Wan Y; Liang Y; Liang F; Shen N; Shinozuka K; Yu JT; Ran C; Quan Q; Tanzi RE; Zhang C
    J Alzheimers Dis; 2019; 72(3):761-771. PubMed ID: 31640096
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Protective effects of curcumin and Ginkgo biloba extract combination on a new model of Alzheimer's disease.
    Assi AA; Farrag MMY; Badary DM; Allam EAH; Nicola MA
    Inflammopharmacology; 2023 Jun; 31(3):1449-1464. PubMed ID: 36856916
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Non-invasive optical imaging of retinal Aβ plaques using curcumin loaded polymeric micelles in APP
    Chibhabha F; Yang Y; Ying K; Jia F; Zhang Q; Ullah S; Liang Z; Xie M; Li F
    J Mater Chem B; 2020 Aug; 8(33):7438-7452. PubMed ID: 32662804
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Curcumin inhibits formation of amyloid beta oligomers and fibrils, binds plaques, and reduces amyloid in vivo.
    Yang F; Lim GP; Begum AN; Ubeda OJ; Simmons MR; Ambegaokar SS; Chen PP; Kayed R; Glabe CG; Frautschy SA; Cole GM
    J Biol Chem; 2005 Feb; 280(7):5892-901. PubMed ID: 15590663
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Synthetic Curcumin Analogs as Inhibitors of β -Amyloid Peptide Aggregation: Potential Therapeutic and Diagnostic Agents for Alzheimer's Disease.
    Bukhari SN; Jantan I
    Mini Rev Med Chem; 2015; 15(13):1110-21. PubMed ID: 26420724
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Examining the potential clinical value of curcumin in the prevention and diagnosis of Alzheimer's disease.
    Goozee KG; Shah TM; Sohrabi HR; Rainey-Smith SR; Brown B; Verdile G; Martins RN
    Br J Nutr; 2016 Feb; 115(3):449-65. PubMed ID: 26652155
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A small molecule transcription factor EB activator ameliorates beta-amyloid precursor protein and Tau pathology in Alzheimer's disease models.
    Song JX; Malampati S; Zeng Y; Durairajan SSK; Yang CB; Tong BC; Iyaswamy A; Shang WB; Sreenivasmurthy SG; Zhu Z; Cheung KH; Lu JH; Tang C; Xu N; Li M
    Aging Cell; 2020 Feb; 19(2):e13069. PubMed ID: 31858697
    [TBL] [Abstract][Full Text] [Related]  

  • 11. REVIEW: Curcumin and Alzheimer's disease.
    Hamaguchi T; Ono K; Yamada M
    CNS Neurosci Ther; 2010 Oct; 16(5):285-97. PubMed ID: 20406252
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Natural products as a rich source of tau-targeting drugs for Alzheimer's disease.
    Calcul L; Zhang B; Jinwal UK; Dickey CA; Baker BJ
    Future Med Chem; 2012 Sep; 4(13):1751-61. PubMed ID: 22924511
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Challenges associated with curcumin therapy in Alzheimer disease.
    Belkacemi A; Doggui S; Dao L; Ramassamy C
    Expert Rev Mol Med; 2011 Nov; 13():e34. PubMed ID: 22051121
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Curcumin and Its Derivatives as Theranostic Agents in Alzheimer's Disease: The Implication of Nanotechnology.
    Shabbir U; Rubab M; Tyagi A; Oh DH
    Int J Mol Sci; 2020 Dec; 22(1):. PubMed ID: 33375513
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Recent Progress in the Drug Development for the Treatment of Alzheimer's Disease Especially on Inhibition of Amyloid-peptide Aggregation.
    Liu Y; Cong L; Han C; Li B; Dai R
    Mini Rev Med Chem; 2021; 21(8):969-990. PubMed ID: 33245270
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Curcumin hybrid molecules for the treatment of Alzheimer's disease: Structure and pharmacological activities.
    Zang WB; Wei HL; Zhang WW; Ma W; Li J; Yao Y
    Eur J Med Chem; 2024 Feb; 265():116070. PubMed ID: 38134747
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A Curcumin Analog Exhibits Multiple Biologic Effects on the Pathogenesis of Alzheimer's Disease and Improves Behavior, Inflammation, and β-Amyloid Accumulation in a Mouse Model.
    Su IJ; Chang HY; Wang HC; Tsai KJ
    Int J Mol Sci; 2020 Jul; 21(15):. PubMed ID: 32751716
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Curcumin ameliorates insulin signalling pathway in brain of Alzheimer's disease transgenic mice.
    Feng HL; Dang HZ; Fan H; Chen XP; Rao YX; Ren Y; Yang JD; Shi J; Wang PW; Tian JZ
    Int J Immunopathol Pharmacol; 2016 Dec; 29(4):734-741. PubMed ID: 27466310
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Neuroprotective potentials of Lead phytochemicals against Alzheimer's disease with focus on oxidative stress-mediated signaling pathways: Pharmacokinetic challenges, target specificity, clinical trials and future perspectives.
    Ayaz M; Mosa OF; Nawaz A; Hamdoon AAE; Elkhalifa MEM; Sadiq A; Ullah F; Ahmed A; Kabra A; Khan H; Murthy HCA
    Phytomedicine; 2024 Feb; 124():155272. PubMed ID: 38181530
    [TBL] [Abstract][Full Text] [Related]  

  • 20. PLGA-Based Curcumin Delivery System: An Interesting Therapeutic Approach in the Treatment of Alzheimer's Disease.
    Shahbaz SK; Koushki K; Sathyapalan T; Majeed M; Sahebkar A
    Curr Neuropharmacol; 2022; 20(2):309-323. PubMed ID: 34429054
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.